全文获取类型
收费全文 | 8658篇 |
免费 | 596篇 |
国内免费 | 26篇 |
专业分类
耳鼻咽喉 | 63篇 |
儿科学 | 316篇 |
妇产科学 | 116篇 |
基础医学 | 1581篇 |
口腔科学 | 264篇 |
临床医学 | 772篇 |
内科学 | 1412篇 |
皮肤病学 | 439篇 |
神经病学 | 993篇 |
特种医学 | 472篇 |
外科学 | 934篇 |
综合类 | 70篇 |
一般理论 | 1篇 |
预防医学 | 380篇 |
眼科学 | 107篇 |
药学 | 629篇 |
中国医学 | 8篇 |
肿瘤学 | 723篇 |
出版年
2023年 | 42篇 |
2022年 | 49篇 |
2021年 | 157篇 |
2020年 | 121篇 |
2019年 | 101篇 |
2018年 | 184篇 |
2017年 | 158篇 |
2016年 | 208篇 |
2015年 | 221篇 |
2014年 | 267篇 |
2013年 | 324篇 |
2012年 | 458篇 |
2011年 | 463篇 |
2010年 | 258篇 |
2009年 | 284篇 |
2008年 | 435篇 |
2007年 | 448篇 |
2006年 | 443篇 |
2005年 | 416篇 |
2004年 | 430篇 |
2003年 | 399篇 |
2002年 | 404篇 |
2001年 | 291篇 |
2000年 | 241篇 |
1999年 | 215篇 |
1998年 | 111篇 |
1997年 | 79篇 |
1996年 | 68篇 |
1995年 | 90篇 |
1994年 | 68篇 |
1993年 | 85篇 |
1992年 | 113篇 |
1991年 | 114篇 |
1990年 | 122篇 |
1989年 | 105篇 |
1988年 | 94篇 |
1987年 | 81篇 |
1986年 | 87篇 |
1985年 | 82篇 |
1984年 | 81篇 |
1983年 | 60篇 |
1982年 | 49篇 |
1981年 | 45篇 |
1979年 | 72篇 |
1978年 | 46篇 |
1977年 | 47篇 |
1975年 | 42篇 |
1974年 | 42篇 |
1973年 | 55篇 |
1968年 | 42篇 |
排序方式: 共有9280条查询结果,搜索用时 15 毫秒
101.
102.
103.
104.
Efficacy response of inhaled beclomethasone dipropionate in asthma is proportional to dose and is improved by formulation with a new propellant 总被引:4,自引:0,他引:4
Busse WW Brazinsky S Jacobson K Stricker W Schmitt K Vanden Burgt J Donnell D Hannon S Colice GL 《The Journal of allergy and clinical immunology》1999,104(6):1215-1222
BACKGROUND: This study tested the hypothesis that there would be improved asthma control with increasing doses of beclomethasone dipropionate (BDP) formulated in hydrofluoroalkane-134a (HFA-BDP) and the standard chlorofluorocarbon propellants (CFC-BDP). Because HFA-BDP has improved lung deposition compared with CFC-BDP, this study also tested the hypothesis that HFA-BDP would provide more effective control of asthma than CFC-BDP. METHODS: In this multicenter, randomized, parallel-group blinded study, asthmatic subjects who had deterioration in asthma control after discontinuation of inhaled corticosteroids were randomized to receive one of 6 possible treatments: 100 microg/d, 400 microg/d, or 800 microg/d of HFA-BDP or 100 microg/d, 400 microg/d, or 800 microg/d of CFC-BDP for 6 weeks. Changes in spirometry, daytime asthma symptom and nighttime asthma-related sleep disturbance scores, morning and evening peak expiratory flows, and daily use of inhaled beta-agonist for symptom control on diary cards were assessed over 6 weeks of treatment. RESULTS: Three hundred twenty-three patients were randomized to the 6 treatment groups, which had similar demographics and baseline lung function. There were significantly larger changes from baseline at week 6 in FEV(1) percent predicted with increasing doses of both HFA-BDP and CFC-BDP. The FEV(1) percent predicted dose-response curve for HFA-BDP was shifted to the left compared with the dose-response curve for CFC-BDP. By using the Finney bioassay method, it was calculated that 2.6 times as much CFC-BDP would be required to achieve the same improvement in FEV(1) percent predicted as HFA-BDP (95% confidence interval, 1.1-11.6). All treatment groups except the 100 microg/d CFC-BDP group tolerated study drug well. Ten (17%) of 59 patients in this group reported an acute asthma episode, increased asthma symptoms (6 of the 8 reports of increased asthma symptoms were classified as severe), or both, and 8 patients withdrew from the study (3 for adverse events related to asthma). CONCLUSIONS: Increasing doses of inhaled corticosteroids lead to improved lung function and asthma control. Moreover, the reformulation of BDP in HFA enables effective asthma control at much lower doses than CFC-BDP. 相似文献
105.
Transgenic rat model of Huntington's disease 总被引:12,自引:0,他引:12
von Hörsten S Schmitt I Nguyen HP Holzmann C Schmidt T Walther T Bader M Pabst R Kobbe P Krotova J Stiller D Kask A Vaarmann A Rathke-Hartlieb S Schulz JB Grasshoff U Bauer I Vieira-Saecker AM Paul M Jones L Lindenberg KS Landwehrmeyer B Bauer A Li XJ Riess O 《Human molecular genetics》2003,12(6):617-624
Huntington's disease (HD) is a late manifesting neurodegenerative disorder in humans caused by an expansion of a CAG trinucleotide repeat of more than 39 units in a gene of unknown function. Several mouse models have been reported which show rapid progression of a phenotype leading to death within 3-5 months (transgenic models) resembling the rare juvenile course of HD (Westphal variant) or which do not present with any symptoms (knock-in mice). Owing to the small size of the brain, mice are not suitable for repetitive in vivo imaging studies. Also, rapid progression of the disease in the transgenic models limits their usefulness for neurotransplantation. We therefore generated a rat model transgenic of HD, which carries a truncated huntingtin cDNA fragment with 51 CAG repeats under control of the native rat huntingtin promoter. This is the first transgenic rat model of a neurodegenerative disorder of the brain. These rats exhibit adult-onset neurological phenotypes with reduced anxiety, cognitive impairments, and slowly progressive motor dysfunction as well as typical histopathological alterations in the form of neuronal nuclear inclusions in the brain. As in HD patients, in vivo imaging demonstrates striatal shrinkage in magnetic resonance images and a reduced brain glucose metabolism in high-resolution fluor-deoxy-glucose positron emission tomography studies. This model allows longitudinal in vivo imaging studies and is therefore ideally suited for the evaluation of novel therapeutic approaches such as neurotransplantation. 相似文献
106.
Ambiguous Role of Interleukin-12 in Yersinia enterocolitica Infection in Susceptible and Resistant Mouse Strains 总被引:1,自引:0,他引:1 下载免费PDF全文
Erwin Bohn Edgar Schmitt Claudia Bielfeldt Annette Noll Ralf Schulte Ingo B. Autenrieth 《Infection and immunity》1998,66(5):2213-2220
Endogenous interleukin-12 (IL-12) mediates protection against Yersinia enterocolitica in C57BL/6 mice by triggering gamma interferon (IFN-γ) production in NK and CD4+ T cells. Administration of exogenous IL-12 confers protection against yersiniae in Yersinia-susceptible BALB/c mice but exacerbates yersiniosis in resistant C57BL/6 mice. Therefore, we wanted to dissect the different mechanisms exerted by IL-12 during Yersinia infections by using different models of Yersinia-resistant and -susceptible mice, including resistant C57BL/6 mice, susceptible BALB/c mice, intermediate-susceptible wild-type 129/Sv mice, 129/Sv IFN-γ-receptor-deficient (IFN-γR−/−) mice and C57BL/6 tumor necrosis factor (TNF) receptor p55 chain-deficient (TNFR p55−/−) mice. IFN-γR−/− mice turned out to be highly susceptible to infection by Y. enterocolitica compared with IFN-γR+/+ mice. Administration of IL-12 was protective in IFN-γR+/+ mice but not in IFN-γR−/− mice, suggesting that IFN-γR-induced mechanisms are essential for IL-12-induced resistance against yersiniae. BALB/c mice could be rendered Yersinia resistant by administration of anti-CD4 antibodies or by administration of IL-12. In contrast, C57BL/6 mice could be rendered more resistant by administration of transforming growth factor β (TGF-β). Furthermore, IL-12-triggered toxic effects in C57BL/6 mice were abrogated by coadministration of TGF-β. While administration of IL-12 alone increased TNF-α levels, administration of TGF-β or TGF-β plus IL-12 decreased both TNF-α and IFN-γ levels in Yersinia-infected C57BL/6 mice. Moreover, IL-12 did not induce toxicity in Yersinia-infected TNFR p55−/− mice, suggesting that TNF-α accounts for IL-12-induced toxicity. Taken together, IL-12 may induce different effector mechanisms in BALB/c and C57BL/6 mice resulting either in protection or exacerbation. These results are important for understanding the critical balance of proinflammatory and regulatory cytokines in bacterial infections which is decisive for beneficial effects of cytokine therapy. 相似文献
107.
Partha Biswas Govindsamy Kumaramanickavel Corinne Stoetzel Renaud Quillet Jyotirmay Biswas Elisabeth Lajeunie Dominique Renier Fabienne Perrin‐Schmitt 《American journal of medical genetics. Part A》2002,109(3):218-225
Saethre‐Chotzen syndrome is an autosomal dominant disease characterized by craniosynostosis, ptosis, and limb and external ear abnormalities. Variable expressivity is a well‐known phenomenon in this disorder. A large Indian family has been recently identified as carrying a nonsense TWIST mutation (Q28 X) in 17 members, of whom 16 were examined in detail. Only 4 (25%) of the patients showed patent craniostenosis, namely, oxycephaly. The penetrance of craniosynostosis in this family is lower than previously reported in the literature. Fifteen patients (93%) had moderate to severe ptosis. Minor limb and external ear abnormalities were present in most patients. Eyelid features were the hallmark of the disease for 12 members of the family, suggesting that mutations in TWIST may lead to a phenotype with mainly palpebral features and no craniostenosis. The clinical analysis of this large family clearly illustrates the significant variable expressivity, probably related to haploinsufficiency because of the TWIST mutation. This phenotypic variability remains unclear but could be the result of modifier genes and/or genetic background effect, as noticed previously in the transgenic twist‐null heterozygous mice. © 2002 Wiley‐Liss, Inc. 相似文献
108.
Gamborino E Carrilho C Ferro J Khan MS Garcia C Suarez MC Yokoyama H Schmitt FC 《Diagnostic cytopathology》2000,23(5):322-325
Fine-needle aspiration (FNA) cytology was performed on 15 patients with peripheral lymphadenopathy and/or skin lesions referred to the Department of Pathology of the Hospital Central of Maputo, Maputo, Mozambique. Epitrochlear lymph nodes were the most frequently aspirated site. All aspirates allowed diagnoses of Kaposi's sarcoma (KS). Smears contained loosely cohesive clusters of bland spindle cells, with a radial arrangement and nuclear crush artifacts. These diagnostic clues have not been described in other spindle-cell intranodal lesions that should be considered in differential diagnoses. Taking into consideration the high prevalence of AIDS and limited resources for diagnosis in Africa, FNA cytology appears to be a useful method for the diagnosis of KS in developing countries, reducing the necessity for surgical lymph node excision. 相似文献
109.
Amadou Kane Edmond Ekué Creppy Angelika Roth Robert Röschenthaler Guy Dirheimer 《Archives of toxicology》1986,58(4):219-224
The distribution of a single low dose of [3H]ochratoxin A (OTA) in different tissues of male Wistar rats, after administration by intubation, was investigated after 5 h, 24 h and 48 h. This dose corresponds to concentrations encountered in naturally contaminated feed (4 ppm). The distribution of [3H]-label varied with the time elapsed after administration; at 5 h the highest specific label was found in the stomach contents and in decreasing order in: intestinal contents, lung, liver, kidney, heart, fat, intestine, testes, and the lowest in muscles, spleen and brain. With exception of brain, fat, stomach and lung, all tissues showed maximum levels at 24 h, after which time the label decreased steadily, whereas in fat it increased.After a 12-week feeding experiment, with doses of 288.8 g/kg corresponding to an intake of 4 ppm in feed each 48 h, the DNA in liver and kidneys was investigated for damage. By the alkaline elution method combined with micro-spectrofluorimetric determinations of DNA, evidence for DNA single-strand breaks was obtained. These findings support reports on the carcinogenic action of OTA. 相似文献
110.
E J Schmitt 《Klinische Monatsbl?tter für Augenheilkunde》1984,184(3):238-239
A simplified irrigation/aspiration system has been developed by the author in cooperation with the Klein company of Heidelberg. The suction is produced by connecting the instrument to a commonly used aspirator. The aspiration force is regulated by means of a foot-pedal, which regulates the amount of "bypass air" delivered through a special tube connected to the irrigation/aspiration handpiece. This simple i/a system represents a low-priced alternative to other systems already on the market. 相似文献